Related Experiment Video
Updated: Jan 15, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Beyond recurrence: redefining atrial fibrillation burden as a prognostic and therapeutic endpoint
Andrea Ballatore1,2, Carola Griffith Brookles1,2, Mark O'Neill3,4
1Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza Hospital, Turin, Italy.
Insights
Atrial fibrillation (AF) burden, the percentage of time spent in arrhythmia, offers a more accurate measure of treatment success than traditional methods. Further research is needed to standardize its definition and application in clinical practice.
Area of Science:
- Cardiology
- Medical Technology
Background:
- Traditional atrial fibrillation (AF) classification by episode duration and binary recurrence assessment (e.g., >30s) have limitations.
- Current methods may not accurately reflect time in arrhythmia or correlate well with clinical outcomes after interventions like catheter ablation (CA).
Purpose of the Study:
- To review the impact and prognostic value of atrial fibrillation burden.
- To highlight challenges, including the lack of a standardized definition and consensus on its clinical use.
- To explore the role of advanced monitoring strategies, including wearables and AI.
Main Methods:
- Literature review summarizing current knowledge on AF burden.
- Discussion of emerging evidence on AF burden's clinical relevance.
- Exploration of future monitoring technologies.
Main Results:
- AF burden, defined as the percentage of time in arrhythmia, shows promise in reflecting CA outcomes and predicting prognosis in certain patient groups.
- Existing definitions are inconsistent, necessitating standardization.
- Continuous monitoring strategies, potentially enhanced by wearables and AI, are crucial.
Conclusions:
- AF burden may offer a more precise assessment of AF management than traditional metrics.
- Standardization of AF burden definition and integration into clinical practice are essential.
- Technological advancements in monitoring hold significant potential for improved AF management.
Abstract:
Atrial fibrillation (AF) has traditionally been classified by episode duration, whereas rhythm control outcomes-via antiarrhythmic drugs or catheter ablation (CA)-have typically been evaluated using a binary approach, with any arrhythmic recurrence lasting over 30 s deemed a failure. Both definitions have notable limitations. Clinical classification often fails to accurately represent the actual time spent in arrhythmia, and AF recurrence following CA does not always correlate well with relevant clinical outcomes. This has driven increasing interest in the concept of AF burden which, although not consistently defined in literature, generally refers to the total percentage of time spent in arrhythmia during the monitoring period. Emerging evidence suggests that AF burden more accurately reflects the impact of CA on symptoms and serves as a valuable prognostic marker, particularly in specific patient subgroups.This review aims to summarise current knowledge on the impact and prognostic value of AF burden, highlighting unsolved issues, such as the absence of a standardised definition and the need for consensus on its use. Additionally, the review underscores the significance of monitoring strategies, highlighting the potential role that wearable devices and artificial intelligence could play in enhancing continuous monitoring in the near future.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Endocarditis III: Medical Management
Atherosclerosis III: Management
Cardiomyopathy V: Interprofessional Care
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VI: Adjunct Therapies

